ABCG5 p.Asn591Gln

[switch to full view]
Comments [show]
Publications
PMID: 24584735 [PubMed] Suzuki S et al: "Inhibition of post-translational N-glycosylation by HRD1 that controls the fate of ABCG5/8 transporter."
No. Sentence Comment
50 Single substitution of glutamine for asparagine at position 584 (N584Q) and at position 591 (N591Q) in human ABCG5 reduced the apparent molecular mass to a similar extent between two mutants (Figure 1b).
X
ABCG5 p.Asn591Gln 24584735:50:93
status: NEW
Login to comment

51 Double mutation (N584Q/N591Q) further reduced the band size identical to those of EndoH- and PNGase F-treated ABCG5 proteins (Figure 1b,c; Supplementary Figure S4), indicating that human ABCG5 contains two N-linked glycans at positions 584 and 591.
X
ABCG5 p.Asn591Gln 24584735:51:23
status: NEW
Login to comment

67 (b) Steady-state expression of monomeric Myc-tagged WT-, N584Q-, N591Q- and N584Q-/N591Q-ABCG5 was analyzed by immunoblotting.
X
ABCG5 p.Asn591Gln 24584735:67:65
status: NEW
X
ABCG5 p.Asn591Gln 24584735:67:83
status: NEW
Login to comment

68 (c) Endo H (500 U) and PNGase F (500 U) sensitivity of Myc-tagged WT-, N584Q-, N591Q- and N584Q-/N591Q-ABCG5 proteins shown in (b).
X
ABCG5 p.Asn591Gln 24584735:68:79
status: NEW
X
ABCG5 p.Asn591Gln 24584735:68:97
status: NEW
Login to comment

83 (f-i) Pulse chase (pulse labeled for 10 min) of HEK293 cells expressing Myc-tagged WT-, N584Q- and N591Q-ABCG5 (f).
X
ABCG5 p.Asn591Gln 24584735:83:99
status: NEW
Login to comment

84 Relative quantity of each glycosylated form of WT-ABCG5 (g), N591Q-ABCG5 (h) and N584Q-ABCG5 (i) within all ABCG5 was quantified.
X
ABCG5 p.Asn591Gln 24584735:84:61
status: NEW
Login to comment

91 To further characterize the glycosylation timing of each Asn residues (N584 and N591) of ABCG5 protein, mutational analysis using N584Q- and N591Q-ABCG5 constructs were performed.
X
ABCG5 p.Asn591Gln 24584735:91:141
status: NEW
Login to comment

92 Notably, Non-G forms of both N584Q and N591Q ABCG5 proteins were abundantly expressed (Figure 2f,h,i: 70.1% vs. 54.6%), indicating that both Asn residues (N584 and N591) have the potential to be post-translationally glycosylated although the tendency seems to be different among residues.
X
ABCG5 p.Asn591Gln 24584735:92:39
status: NEW
Login to comment

93 Consistently, pulse-chase analysis using N584Q and N591Q ABCG5 revealed that the expression level of glycosylated forms of N584Q and N591Q ABCG5 are gradually increased during the chase period (Figure 2f,h,i: 45.4% to 72.6% for N584Q-ABCG5; 29.9% to 71.9% for N591Q-ABCG5).
X
ABCG5 p.Asn591Gln 24584735:93:51
status: NEW
X
ABCG5 p.Asn591Gln 24584735:93:133
status: NEW
X
ABCG5 p.Asn591Gln 24584735:93:260
status: NEW
Login to comment

94 Because of the high expression of Non-G form of N591Q ABCG5 at 0-min chase (Figure 2f,h 70.1%) and of the time-dependent increase of Mono-G form of ABCG5 (Figure 2f,h), we can deduce that most of the N584 residue of ABCG5 is post-translationally glycosylated, while N591 residue is both co- and post-translationally glycosylated.
X
ABCG5 p.Asn591Gln 24584735:94:48
status: NEW
Login to comment

302 Glycosylation-defective mutants N584Q-, N591Q-, N584Q/N591Q-ABCG5, N619Q-ABCG8, and E3-defective mutants C291S/C329S-HRD1, H260Q CHIP and C42S-RMA1 were generated using the QuikChange II site-directed mutagenesis kit (Stratagene, La Jolla, CA) according to previous reports12,17,32-34 .
X
ABCG5 p.Asn591Gln 24584735:302:40
status: NEW
X
ABCG5 p.Asn591Gln 24584735:302:54
status: NEW
Login to comment